CHU Angers

Angers, Maine-et-loire 49933

1 studies enrolling now · 5 studies all time

What they study most

Cytomegalovirus (CMV), Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Metastatic or Unresectable Cutaneous Melanoma, Myelodysplastic Syndrome, Myelodysplastic Syndromes, Polycythemia Vera

Studies at this site

• Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera — Recruiting now
• A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) — Running, not enrolling
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed